Multiple Sclerosis: The Role of Mitochondrial Dysfunction in IR Resistance (MS-MIDY)
Multiple Sclerosis: The Role of Mitochondrial Dysfunction in Insulin Resistance
Sponsor: Comenius University
Listed as NCT03052595, this observational or N/A phase trial focuses on Mitochondrial Alteration and Multiple Sclerosis and remains completed. Sponsored by Comenius University, it has been updated 13 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2023 — Jul 2024 [monthly]
Completed
Status: Unknown Status → Completed
-
Mar 2022 — May 2023 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Dec 2021 — Mar 2022 [monthly]
Recruiting
▶ Show 8 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Jan 2019 — Nov 2020 [monthly]
Recruiting
-
Jun 2018 — Jan 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Feb 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Comenius University
- Slovak Academy of Sciences
For direct contact, visit the study record on ClinicalTrials.gov .